Amir Tavakkol Selected Research

Terbinafine (Lamisil)

7/2021	Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.
6/2014	Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis.
7/2008	Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
1/2007	The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis.
11/2006	Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trial.
8/2006	The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis.
3/2006	Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
12/2005	Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality.
5/2005	The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amir Tavakkol Research Topics

Disease

11	Onychomycosis (Tinea Unguium) 07/2021 - 05/2005
2	Infections 01/2018 - 07/2014
2	Mycoses (Diseases, Fungus) 07/2014 - 12/2007
1	Vulvovaginal Candidiasis 01/2018
1	Tinea Pedis (Athlete's Foot) 04/2013
1	Tinea Capitis 07/2008
1	Nail Diseases (Nail Disease) 12/2005
1	Down Syndrome (Down's Syndrome) 05/2005

Drug/Important Bio-Agent (IBA)

9	Terbinafine (Lamisil)FDA LinkGeneric 07/2021 - 05/2005
5	Antifungal AgentsIBA 07/2014 - 05/2005
3	Fluconazole (Zonal)FDA LinkGeneric 01/2018 - 05/2005
3	luliconazoleIBA 07/2014 - 04/2013
3	IronIBA 11/2006 - 03/2006
2	SolutionsIBA 07/2021 - 07/2014
2	potassium hydroxideIBA 01/2018 - 07/2008
2	Griseofulvin (Grifulvin V)FDA LinkGeneric 07/2008 - 12/2005
2	Itraconazole (Sporanox)FDA LinkGeneric 12/2005 - 05/2005
1	AzolesIBA 01/2018
1	LanosterolIBA 01/2018
1	VT-1161IBA 01/2018
1	imidazoleIBA 07/2014
1	Ciclopirox (Loprox)FDA LinkGeneric 06/2014
1	amorolfineIBA 06/2014
1	posaconazole FDA Link 09/2011
1	SuspensionsIBA 07/2008
1	Antihypertensive Agents (Antihypertensives)IBA 03/2006
1	LipidsIBA 03/2006
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2006
1	Ketoconazole (Nizoral)FDA LinkGeneric 12/2005
1	AllylamineIBA 05/2005

Therapy/Procedure

4	Debridement 01/2007 - 03/2006
1	Aftercare (After-Treatment) 01/2018
1	Drug Therapy (Chemotherapy) 12/2007
1	Therapeutics 01/2007